[ 18 F]FDG-PET accurately identifies pathological response early upon neoadjuvant immune checkpoint blockade in head and neck squamous cell carcinoma.
Joris L VosCharlotte L ZuurLaura A SmitJan Paul de BoerAbrahim Al-MamganiMichiel W M van den BrekelJohn B A G HaanenWouter V VogelPublished in: European journal of nuclear medicine and molecular imaging (2021)
gov/ , NCT03003637, December 28, 2016.